Research Article

Evaluation of Drug Susceptibility of Microorganisms in Odontogenic Inflammations and Dental Surgery Procedures Performed on an Outpatient Basis

Table 4

Distribution of susceptibility in individual groups of bacteria depending on the antibacterial drug.

Antibacterial agent
PAUGVaTZPCCMZGBsCXMCIPFEPAM
SpeciesNnNs%nNs%nNs%nNs%nNs%nNs%nNs%nNs%nNs%nNs%nNs%nNs%

Gram-positive anaerobic
 Actinomyces naeslundii17171270.591717100.00171164.71171588.24171588.24171376.4700NA00NA00NA00NA00NA00NA
 Actinomyces odontolyticus44375.0044100.004375.0044100.0044100.00400.0000NA00NA00NA00NA00NA00NA
 Propionibacterium propionicum44250.0044100.004375.002150.0044100.00400.0000NA00NA00NA00NA00NA00NA
 Clostridium perfringens333100.0033100.0033100.0033100.0033100.00300.0000NA00NA00NA00NA00NA00NA
 Actinomyces israelii33266.6733100.003266.672150.0022100.00200.0000NA00NA00NA00NA00NA00NA
 Clostridium sporogenes22150.0022100.00200.00200.002150.0022100.0000NA00NA00NA00NA00NA00NA
 Actinomyces meyeri222100.0022100.0022100.0022100.0022100.00200.0000NA00NA00NA00NA00NA00NA
 Clostridium novyi biovar A222100.0022100.0022100.0022100.002150.0022100.0000NA00NA00NA00NA00NA00NA
 Clostridium butyricum1100.0011100.00100.0011100.0011100.0011100.0000NA00NA00NA00NA00NA00NA
 Clostridium chauvoei1100.0011100.00100.00100.0011100.0011100.0000NA00NA00NA00NA00NA00NA
 Clostridium novyi1100.0011100.00100.0011100.0011100.0011100.0000NA00NA00NA00NA00NA00NA
 Clostridium tertium1100.0011100.0011100.0011100.0011100.0011100.0000NA00NA00NA00NA00NA00NA
 Actinomyces viscosus111100.0011100.0011100.0000NA11100.00100.0000NA00NA00NA00NA00NA00NA

Gram-negative anaerobic
 Bacteroides ovatus111100.0011100.0011100.0011100.0000NA00NA00NA00NA00NA00NA00NA00NA
 Fusobacterium nucleatum111100.0011100.0011100.0011100.0011100.00100.0000NA00NA00NA00NA00NA00NA

Gram-positive aerobic
 Streptococcus pneumoniae311100.0000NA00NA00NA3266.6700NA00NA200.0000NA100.0000NA00NA
 Staphylococcus aureus200NA00NA00NA00NA22100.0000NA11100.0022100.0000NA00NA00NA00NA
 Staphylococcus epidermidis1100.0000NA00NA00NA11100.0000NA00NA11100.0000NA00NA00NA00NA

Gram-negative aerobic
 Klebsiella oxytoca300NA3133.3300NA00NA00NA00NA22100.0033100.0033100.0033100.0033100.003133.33
 Enterobacter cloacae200NA200.0000NA00NA00NA00NA22100.0022100.0022100.0022100.00200.00200.00
 Escherichia coli200NA100.0000NA00NA00NA00NA11100.0011100.0011100.0011100.0011100.00100.00
 Klebsiella pneumoniae200NA2150.0000NA00NA00NA00NA22100.002150.0022100.0022100.0022100.00200.00
 Burkholderia cepacia100NA100.0000NA00NA00NA00NA11100.0011100.0000NA11100.0011100.0000NA
 Chryseobacterium indologenes100NA11100.0000NA00NA00NA00NA11100.0000NA11100.0011100.0011100.00100.00
 Enterobacter aerogenes100NA100.0000NA00NA00NA00NA11100.0011100.0011100.0011100.0011100.00100.00
 Enterobacter kobei100NA100.0000NA00NA00NA00NA11100.0011100.0011100.0011100.0011100.00100.00
 Hafnia alvei100NA100.0000NA00NA00NA00NA11100.0011100.0011100.0011100.00100.00100.00
 Providencia rustigianii100NA100.0000NA00NA00NA00NA11100.0011100.00100.0011100.0000NA100.00
 Serratia odorifera100NA100.0000NA00NA00NA00NA11100.0011100.0011100.00111100.0011100.00100.00

N, number of strains of a given microorganism cultured; n, number of strains for which susceptibility to a given antibiotic has been determined; Ns, number of strains shown to be susceptible to a given antibacterial agent; %, percentage of bacteria susceptible to a given antibacterial agent; NA, no indications to assess the effect of a particular antibacterial agent on the test microorganism (according to the EUCAST 8.1 guidelines); P, penicillin; AUG, amoxicillin with clavulanic acid; Va, vancomycin; TZP, piperacillin with tazobactam; CC, clindamycin; MZ, metronidazole; G, gentamicin; Bs, sulfamethoxazole with trimethoprim (biseptol); CXM, cefuroxime; CIP, ciprofloxacin; FEP, cefepime; AM, ampicillin.